Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$30.7M Buy
158,746
+124
+0.1% +$21.6K 6.2% 5
2026
Q1
$27.1M Sell
158,622
-6,132
-4% -$1.2M 5.97% 7
2025
Q4
$37.1M Sell
164,754
-5,566
-3% -$1.21M 6.68% 4
2025
Q3
$32.4M Buy
170,320
+1,984
+1% +$361K 5.73% 6
2025
Q2
$26.5M Buy
+168,336
New +$25.3M 5.42% 7

Other funds holding IQV

Act Two Investors's IQV Position: Q2 2026 in Review

Act Two Investors increased its IQVIA (IQV) stake by 0.08% in Q2 2026, buying an estimated $21.6K and bringing the position to 158,746 shares worth $30.7M. The position accounts for 6.2% of the portfolio, ranked #5.

Act Two Investors first reported a position in IQV in Q2 2025 and has held it in 5 quarters since. The position peaked at $37.1M in Q4 2025. 1,090 funds tracked by Wall St. Rank hold IQV as of Q2 2026.

  • Act Two Investors held 158,746 shares of IQVIA worth $30.7M as of Q2 2026.
  • Act Two Investors bought 124 IQVIA shares in Q2 2026, an estimated $21.6K.
  • IQVIA made up 6.2% of Act Two Investors's portfolio in Q2 2026, its #5 holding.
  • Act Two Investors first reported a position in IQVIA in Q2 2025 and has held it in 5 quarters since.
  • Act Two Investors's IQVIA position peaked at $37.1M in Q4 2025.
  • 1,090 funds tracked by Wall St. Rank held IQVIA as of Q2 2026.

Based on Act Two Investors's 13F filing for Q2 2026, filed 10 Aug 2026.